Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,289 | 8,455 | 10,749 | 13,466 | 18,257 |
| Receivables | 635 | N/A | N/A | N/A | N/A |
| TOTAL | $10,001 | $8,899 | $11,962 | $15,186 | $21,629 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 56 | 62 | 71 |
| Intangibles | 0 | 0 | 3,139 | 3,139 | 3,139 |
| Other Non-Current Assets | 100 | 2 | 1,226 | 1,264 | 1,302 |
| TOTAL | $100 | $2 | $4,421 | $4,465 | $4,512 |
| Total Assets | $10,101 | $8,901 | $16,383 | $19,651 | $26,141 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,275 | 296 | 812 | 1,046 | 1,375 |
| Accrued Expenses | 391 | 618 | 1,157 | 831 | 3,449 |
| TOTAL | $1,666 | $914 | $2,126 | $2,013 | $4,957 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 156,476 | 151,049 | 152,086 | 152,126 | 152,166 |
| TOTAL | $156,476 | $151,049 | $152,289 | $152,329 | $152,369 |
| Total Liabilities | $158,142 | $151,963 | $154,415 | $154,342 | $157,326 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,462 | 54,392 | 54,392 | 54,392 | 54,392 |
| Common Shares | 75 | 54 | 54 | 54 | 54 |
| Retained earnings | -456,363 | -451,432 | -445,851 | -441,787 | -437,406 |
| TOTAL | $-148,041 | $-143,062 | $-138,032 | $-134,691 | $-131,185 |
| Total Liabilities And Equity | $10,101 | $8,901 | $16,383 | $19,651 | $26,141 |